Pharmaceutical companies are diving deeper into digital health. Earlier this week, Pfizer said it would acquire Resapp Health Ltd, a company that develops smartphone applications for the diagnosis and management of respiratory disease.
The deal would be for $74 million, and Pfizer would acquire Resapp Health through its Australian subsidiary.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,